Minnesota Patent of the Month – January 2025
Chronic back pain has long been a debilitating condition with limited effective treatment options, often leaving patients with prolonged discomfort and reliance on temporary or invasive solutions. Intracept, a pioneer in spinal health innovation, has introduced a groundbreaking approach that leverages existing spinal implants to deliver targeted nerve ablation, offering a revolutionary alternative for long-term pain relief.
This novel method centers on utilizing pedicle screws, commonly inserted during spinal fusion procedures, as conduits for thermal energy delivery. By applying controlled bipolar radiofrequency energy to these pre-existing implants, the Intracept technique effectively ablates the basivertebral nerve, a known pain generator within the vertebrae. This precise and localized nerve modulation disrupts pain transmission, significantly reducing or eliminating chronic discomfort in patients with persistent post-fusion pain.
Unlike traditional nerve ablation techniques, which often require additional surgical intervention, this approach harnesses already implanted hardware to facilitate energy conduction. This eliminates the need for additional incisions, reduces procedural complexity, and minimizes recovery time. Moreover, the ability to precisely target the nerve’s terminus ensures optimal efficacy while preserving surrounding tissue integrity.
The implications of this innovation extend beyond spinal applications. The method’s adaptability allows for potential use in other orthopedic and neuromodulation treatments, paving the way for broader medical advancements. The integration of sensors to monitor energy delivery and tissue response further enhances safety and precision, reinforcing the reliability of this cutting-edge technique.
By transforming existing spinal implants into therapeutic tools, Intracept has redefined how chronic back pain is managed. This advancement not only provides a more efficient and less invasive treatment but also represents a significant leap forward in the field of pain management, offering new hope for millions suffering from debilitating spinal conditions.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
